Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF653 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
mRNA | POLR3GL | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
mRNA | RARRES3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | PRRG1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
mRNA | NPC2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | SOX10 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.0003 |
mRNA | PARP12 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | AADACL2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | SPO11 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | CFAP99 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |